Adrian Hepner's most recent trade in Coya Therapeutics Inc was a trade of 115,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Coya Therapeutics Inc | Adrian Hepner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Adrian Hepner | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
Coya Therapeutics Inc | Adrian Hepner | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock |